@article{ref1,
title="Suicide attempt in a dopamine agonist withdrawal syndrome in Parkinson's disease",
journal="Parkinsonism and related disorders",
year="2024",
author="Espindola, Melisa and Rojas, Natalia González and Vaisentein, Giselle and Da Prat, Gustavo and Cesarini, Martin and Etcheverry, Jose Luis and Gatto, Emilia M.",
volume="121",
number="",
pages="e106017-e106017",
abstract="Dopamine agonist withdrawal syndrome (DAWS) results from the reduction or suspension of dopamine agonist medications; it encompasses mainly psychiatric symptoms, including suicidal behaviors. In patients with Parkinson's disease (PD), the impact of DAWS can be significant in terms of distress and disability; however, we must take this syndrome into account as a threatening condition because suicidal behaviors could be developing in the context of DAWS. Here we present a brief case of DAWS affecting a young man with PD, whom abruptly discontinued DA treatment and developed psychiatric symptoms within two weeks which led to a suicidal attempt.<p /> <p>Language: en</p>",
language="en",
issn="1353-8020",
doi="10.1016/j.parkreldis.2024.106017",
url="http://dx.doi.org/10.1016/j.parkreldis.2024.106017"
}